PRP: Platelet-Rich Plasma

What Is Platelet-Rich Plasma?

One of the main functions of platelets is to help the body heal and repair itself. Platelet-rich plasma (PRP) is obtained from a patient’s own blood and contains an enhanced concentration of platelets (4 to 7 times). Increasing the concentration of platelets accelerates the wound-healing process and forms the foundation for tissue repair. PRP secretes cytokines, induces coagulation, and releases platelet-derived growth factors which stimulate tissue regeneration and healing.

Autologous PRP injections have been used safely in many therapeutic areas, including treatment of facial aging and hair loss. PRP is non-antigenic and contains no synthetic agents resulting in almost no local or systemic reactions. The process for obtaining PRP is FDA-approved and treatments on the face and in the scalp are safe with minimal side effects. Since PRP is derived from the patient’s own blood, it is very well tolerated.

What Does PRP treat?

At Réviance® Plastic Surgery & Aesthetic Center, we use PRP to treat:

Facial Rejuvenation – combined with laser treatments, microneedling and/or injections to treat fine lines, wrinkles, enlarged pores, skin surface texture, elasticity, firmness, discoloration, acne scars, dark under eye circles, age related sun damage, redness, and rosacea. It may also be used on the body to treat stretch marks and scarring. Typically 3 to 5 treatments are performed for ideal outcomes, with a yearly maintenance treatment recommended.

Hair Loss – age related hair loss/thinning also known as androgenic alopecia. PRP can be used in prevention and hair regrowth without grafts, surgery, or plugs. Typically 3 to 10 treatments are performed for ideal outcomes, with 1-2 yearly maintenance treatments recommended.

Who Is a Good Candidate?

PRP is generally considered safe as a treatment for most patients. Contraindications include an active infection, porphyria, cancer, recent or current chemotherapy, hemophilia, platelet disorders, chronic liver pathology, use of anticoagulation therapies such as warfarin, Systemic Lupus Erythematosus, dermatitis, eczema, amyloidosis, scleroderma, and systemic use of corticosteriods such as prednisone, triamcinolone, hydrocortisone within 2 weeks of treatment.